Singapore-based solar manufacturer Maxeon Solar Technologies and Korea-based solar cell and module maker Qcells have announced a global settlement resolving all ongoing patent litigation between the ...

NEW YORK, June 25 (Reuters) - Telehealth provider Hims & Hers Health (HIMS.N), opens new tab may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk's ...

We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best weight loss drugs on this list. TheFly reported on June 17 ...

That buzzy peptide market that Hims & Hers wants in on could be worth close to $2.2 billion next year for the telehealth industry, according to a new estimate. And the amount for Hims & Hers: $440 ...

Last week Danish pharmaceutical company Novo Nordisk, the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, revealed it had suffered a data breach involving “unauthorized access” ...

Danish pharmaceutical giant Novo Nordisk, the world's largest producer of insulin, disclosed a data breach affecting patient information from some clinical trials. Founded in 1923, Novo Nordisk now ...

As cybersecurity threats have proliferated across industries in recent years, biopharma companies have emerged as prominent targets, with intellectual property, patient data and other sensitive ...

Veru (VERU) stock has not been easy to own. The little biotech has spent years persuading investors that its experimental obesity technique can matter in a market dominated by giants. That’s a tough ...

Is HIMS a good stock to buy? We came across a bearish thesis on Hims & Hers Health, Inc. on Valueinvestorsclub.com by Pridwen. In this article, we will summarize the bears’ thesis on HIMS. Hims & Hers ...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the ...